These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31937103)

  • 1. Postprandial Lipemia Modulates Pancreatic Alpha-Cell Function in the Prediction of Type 2 Diabetes Development: The CORDIOPREV Study.
    Pozuelo-Sanchez I; Villasanta-Gonzalez A; Alcala-Diaz JF; Vals-Delgado C; Leon-Acuña A; Gonzalez-Requero A; Yubero-Serrano EM; Luque RM; Caballero-Villarraso J; Quesada I; Ordovas JM; Pérez-Martinez P; Roncero-Ramos I; Lopez-Miranda J
    J Agric Food Chem; 2020 Feb; 68(5):1266-1275. PubMed ID: 31937103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial lipemia induces pancreatic α cell dysfunction characteristic of type 2 diabetes: studies in healthy subjects, mouse pancreatic islets, and cultured pancreatic α cells.
    Niederwanger A; Ciardi C; Tatarczyk T; Khan MI; Hermann M; Mittermair C; Al-Zoairy R; Salzmann K; Pedrini MT
    Am J Clin Nutr; 2014 Nov; 100(5):1222-31. PubMed ID: 25332320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial endotoxemia may influence the development of type 2 diabetes mellitus: From the CORDIOPREV study.
    Camargo A; Jimenez-Lucena R; Alcala-Diaz JF; Rangel-Zuñiga OA; Garcia-Carpintero S; Lopez-Moreno J; Blanco-Rojo R; Delgado-Lista J; Perez-Martinez P; van Ommen B; Malagon MM; Ordovas JM; Perez-Jimenez F; Lopez-Miranda J
    Clin Nutr; 2019 Apr; 38(2):529-538. PubMed ID: 29685478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study.
    Leon-Acuña A; Alcala-Diaz JF; Delgado-Lista J; Torres-Peña JD; Lopez-Moreno J; Camargo A; Garcia-Rios A; Marin C; Gomez-Delgado F; Caballero J; Van-Ommen B; Malagon MM; Perez-Martinez P; Lopez-Miranda J
    Cardiovasc Diabetol; 2016 Apr; 15():68. PubMed ID: 27095446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes.
    Thomsen C; Storm H; Holst JJ; Hermansen K
    Am J Clin Nutr; 2003 Mar; 77(3):605-11. PubMed ID: 12600850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of medications used for the management of diabetes and obesity on postprandial lipid metabolism.
    Eleftheriadou I; Grigoropoulou P; Katsilambros N; Tentolouris N
    Curr Diabetes Rev; 2008 Nov; 4(4):340-56. PubMed ID: 18991602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial.
    Hermansen K; Bækdal TA; Düring M; Pietraszek A; Mortensen LS; Jørgensen H; Flint A
    Diabetes Obes Metab; 2013 Nov; 15(11):1040-8. PubMed ID: 23683069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon antagonism as a potential therapeutic target in type 2 diabetes.
    Bagger JI; Knop FK; Holst JJ; Vilsbøll T
    Diabetes Obes Metab; 2011 Nov; 13(11):965-71. PubMed ID: 21615669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis.
    Perez-Martinez P; Alcala-Diaz JF; Delgado-Lista J; Garcia-Rios A; Gomez-Delgado F; Marin-Hinojosa C; Rodriguez-Cantalejo F; Delgado-Casado N; Perez-Caballero AI; Fuentes-Jimenez FJ; Camargo A; Tinahones FJ; Ordovas JM; Perez-Jimenez F; Lopez-Miranda J
    Eur J Clin Invest; 2014 Nov; 44(11):1053-64. PubMed ID: 25231836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
    Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
    Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial VLDL-TG metabolism in type 2 diabetes.
    Søndergaard E; Johansen RF; Jensen MD; Nielsen S
    Metabolism; 2017 Oct; 75():25-35. PubMed ID: 28964326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.
    Dunning BE; Gerich JE
    Endocr Rev; 2007 May; 28(3):253-83. PubMed ID: 17409288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
    Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between postprandial lipemia and atherogenic factors in healthy subjects by considering gender differences.
    Orem A; Yaman SO; Altinkaynak B; Kural BV; Yucesan FB; Altinkaynak Y; Orem C
    Clin Chim Acta; 2018 May; 480():34-40. PubMed ID: 29408168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of postprandial lipemia in accelerating atherothrombosis.
    Roche HM; Gibney MJ
    J Cardiovasc Risk; 2000 Oct; 7(5):317-24. PubMed ID: 11143761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus.
    Pastromas S; Terzi AB; Tousoulis D; Koulouris S
    Int J Cardiol; 2008 May; 126(1):3-12. PubMed ID: 17689745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Autonomous Dysfunction and Insulin Resistance in Pancreatic α Cells.
    Honzawa N; Fujimoto K; Kitamura T
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of different fractions of whey protein on postprandial lipid and hormone responses in type 2 diabetes.
    Mortensen LS; Holmer-Jensen J; Hartvigsen ML; Jensen VK; Astrup A; de Vrese M; Holst JJ; Thomsen C; Hermansen K
    Eur J Clin Nutr; 2012 Jul; 66(7):799-805. PubMed ID: 22588635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
    Forst T; Anastassiadis E; Diessel S; Löffler A; Pfützner A
    Diabetes Metab Res Rev; 2014 Oct; 30(7):582-9. PubMed ID: 24459063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.